Skip to content
2000
image of Relationship between 21 Medications and Negative Emotions: A Mendelian Randomization Analysis in Asian Populations

Abstract

Objective

Negative emotional states, such as nervousness, anxiety, depression, and tension, exert profound detrimental effects on an individual's quality of life and overall health. Although certain widely prescribed medications have been observed to modulate these emotional states, the existing body of research in this domain remains insufficient. To address this gap, Mendelian randomization (MR) methodologies, leveraging large-scale datasets, were employed to investigate the causal relationships between 21 commonly utilized medications and the manifestation of negative emotions.

Methods

The inverse variance weighting (IVW) method was employed as the primary analytical strategy to analyze causal relationships. MR-Egger, weighted mode, and weighted median approaches were utilized to enhance the robustness of the results. Sensitivity analyses were conducted to assess the stability of the data.

Results

Agents acting on the renin-angiotensin system, β-blocking agents, antithrombotic agents, and salicylic acid and derivatives could reduce the risk of nervousness, anxiety, tension, or depression (OR = 0.61, 95% CI 0.37 to 0.99, = 0.047; OR = 0.59, 95% CI 0.36 to 0.98, = 0.041; OR = 0.55, 95% CI 0.34 to 0.88, = 0.013; OR = 0.61, 95% CI 0.40 to 0.95, = 0.030), with no heterogeneity, horizontal pleiotropy, or reverse causation ( > 0.05).

Conclusion

This study revealed four medications associated with reducing the risk of negative emotions, providing clinicians with a scientific basis for medication selection to better assist patients in alleviating psychological issues and improving their quality of life.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673359046250502104101
2025-05-19
2025-09-09

  • From This Site

    /content/journals/cmc/10.2174/0109298673359046250502104101
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Wang X. Nie X. Zhang F. Wei Y. Zeng W. Zhang Y. Lin H. Functional magnetic resonance imaging of depression: A bibliometrics and meta-analysis. Ann. Gen. Psychiatry 2024 23 1 39 10.1186/s12991‑024‑00525‑x 39449080
    [Google Scholar]
  2. Wang X. Lin H. Jiang X. Ma M. Shi D. Fan C. Shao Y. Wu S. Yu L. Li D. He J. Chen Y. Effect of electroacupuncture and counseling on sub-threshold depression: A study protocol for a multicenter randomized controlled trial. Front. Psychiatry 2020 11 346 10.3389/fpsyt.2020.00346 32411031
    [Google Scholar]
  3. Wang X. Lin Q. Shen M. Lin H. Feng J. Peng L. Huang M. Zhan X. Chen Z. Ma T. Identification of the ingredients and mechanisms of curcumae radix for depression based on network pharmacology and molecular docking. Nat. Prod. Commun. 2021 16 5 1934578X211016643 10.1177/1934578X211016643
    [Google Scholar]
  4. Valencia P.D. Torres-Quispe M.A. Sánchez-Cayo S. Reyes-Aguilar R.F. Acevedo-Cahuana A.G. Factors associated with depressive symptomatology during the COVID-19 pandemic in Mexico: A 2021 national survey. J. Affect. Disord. 2022 317 212 220 10.1016/j.jad.2022.08.088 36041583
    [Google Scholar]
  5. Ren Y. Qian W. Li Z. Liu Z. Zhou Y. Wang R. Qi L. Yang J. Song X. Zeng L. Zhang X. Public mental health under the long-term influence of COVID-19 in China: Geographical and temporal distribution. J. Affect. Disord. 2020 277 893 900 10.1016/j.jad.2020.08.045 33065831
    [Google Scholar]
  6. Li C. Choi P.G. Masuda Y. Highly sensitive and selective gas sensors based on NiO/MnO2 @NiO nanosheets to detect allyl mercaptan gas released by humans under psychological stress. Adv. Sci. 2022 9 27 2202442 10.1002/advs.202202442 35839470
    [Google Scholar]
  7. Han S.K. Joo M.K. Kim J.K. Jeung W. Kang H. Kim D.H. Bifidobacteria-fermented red ginseng and its constituents ginsenoside rd and protopanaxatriol alleviate anxiety/depression in mice by the amelioration of gut dysbiosis. Nutrients 2020 12 4 901 10.3390/nu12040901 32224881
    [Google Scholar]
  8. Ramos-Perdigués S. Baillés E. Mané A. Carreño M. Donaire A. Rumià J. Bargalló N. Boget T. Setoain X. Valdés M. Pintor L. Psychiatric symptoms in refractory epilepsy during the first year after surgery. Neurotherapeutics 2018 15 4 1082 1092 10.1007/s13311‑018‑0652‑1 30066084
    [Google Scholar]
  9. Zhao J. Chen H. Zhuo C. Xia S. Cannabis use and the risk of cardiovascular diseases: A mendelian randomization study. Front. Cardiovasc. Med. 2021 8 676850 10.3389/fcvm.2021.676850 34409073
    [Google Scholar]
  10. Li Z. Zhang B. Liu Q. Tao Z. Ding L. Guo B. Zhang E. Zhang H. Meng Z. Guo S. Chen Y. Peng J. Li J. Wang C. Huang Y. Xu H. Wu Y. Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease. EBioMedicine 2023 90 104543 10.1016/j.ebiom.2023.104543 37002989
    [Google Scholar]
  11. Jin Y. Yu X. Li J. Su M. Li X. Causal effects and immune cell mediators between prescription analgesic use and risk of infectious diseases: A Mendelian randomization study. Front. Immunol. 2023 14 1319127 10.3389/fimmu.2023.1319127 38193081
    [Google Scholar]
  12. Ou, H.; Huang, H.; Xu, Y.; Lin, H.; Wang, X. Systematic druggable genome-wide Mendelian randomization to identify therapeutic targets and dominant flora for ulcerative colitis. Pharmacol. Res. 2025 213 107662 10.1016/j.phrs.2025.107662 39978659
    [Google Scholar]
  13. Ou, H.; Lai, Z.; Ye, X.; Wang, X.; Lin, H. Irritable bowel syndrome and structural brain changes-A two-sample Mendelian randomization study of cortical thickness and surface area. Rev. Esp. Enferm. Dig. 2025 10.17235/reed.2025.10983/2024 40066664
    [Google Scholar]
  14. Bowden J. Del Greco M F. Minelli C. Davey Smith G. Sheehan N.A. Thompson J.R. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: The role of the I2 statistic. Int. J. Epidemiol. 2016 45 6 1961 1974 10.1093/ije/dyw220 27616674
    [Google Scholar]
  15. Ou H. Huang H. Ye X. Lin H. Wang X. The relationship between dietary habits and gastroesophageal reflux disease: A two-sample mendelian randomization study. Curr. Med. Chem. 2024 31 1 13 10.2174/0109298673314174240614091415 38939994
    [Google Scholar]
  16. Burgess S. Scott R.A. Timpson N.J. Davey Smith G. Thompson S.G. Using published data in Mendelian randomization: A blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 2015 30 7 543 552 10.1007/s10654‑015‑0011‑z 25773750
    [Google Scholar]
  17. Bowden J. Davey Smith G. Haycock P.C. Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol. 2016 40 4 304 314 10.1002/gepi.21965 27061298
    [Google Scholar]
  18. Hartwig F.P. Davey Smith G. Bowden J. Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int. J. Epidemiol. 2017 46 6 1985 1998 10.1093/ije/dyx102 29040600
    [Google Scholar]
  19. Bowden J. Davey Smith G. Burgess S. Mendelian randomization with invalid instruments: Effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 2015 44 2 512 525 10.1093/ije/dyv080 26050253
    [Google Scholar]
  20. Raman S. Hyland P. Coogan A.N. Temporal associations between insomnia and depression symptoms in adults during the COVID-19 pandemic: A cross-lagged path modelling analysis. Psychiatry Res. 2022 312 114533 10.1016/j.psychres.2022.114533 35381505
    [Google Scholar]
  21. Ojio Y. Nishida A. Shimodera S. Togo F. Sasaki T. Sleep duration associated with the lowest risk of depression/anxiety in adolescents. Sleep 2016 39 8 1555 1562 10.5665/sleep.6020 27306271
    [Google Scholar]
  22. Zhao G. Ford E.S. Dhingra S. Li C. Strine T.W. Mokdad A.H. Depression and anxiety among US adults: Associations with body mass index. Int. J. Obes. 2009 33 2 257 266 10.1038/ijo.2008.268 19125163
    [Google Scholar]
  23. Lasserre A.M. Glaus J. Vandeleur C.L. Marques-Vidal P. Vaucher J. Bastardot F. Waeber G. Vollenweider P. Preisig M. Depression with atypical features and increase in obesity, body mass index, waist circumference, and fat mass: A prospective, population-based study. JAMA Psychiatry 2014 71 8 880 888 10.1001/jamapsychiatry.2014.411 24898270
    [Google Scholar]
  24. Holmquist S. Nordström A. Nordström P. The association of depression with subsequent dementia diagnosis: A Swedish nationwide cohort study from 1964 to 2016. PLoS Med. 2020 17 1 e1003016 10.1371/journal.pmed.1003016 31917808
    [Google Scholar]
  25. Bowden J. Spiller W. Del Greco M F. Sheehan N. Thompson J. Minelli C. Davey Smith G. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the radial plot and radial regression. Int. J. Epidemiol. 2018 47 6 2100 10.1093/ije/dyy265 30423109
    [Google Scholar]
  26. Hemani G. Tilling K. Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017 13 11 e1007081 10.1371/journal.pgen.1007081 29149188
    [Google Scholar]
  27. Skrivankova V.W. Richmond R.C. Woolf B.A.R. Davies N.M. Swanson S.A. VanderWeele T.J. Timpson N.J. Higgins J.P.T. Dimou N. Langenberg C. Loder E.W. Golub R.M. Egger M. Davey Smith G. Richards J.B. Strengthening the reporting of observational studies in epidemiology using Mendelian randomisation (STROBE-MR): Explanation and elaboration. BMJ 2021 375 2233 n2233 10.1136/bmj.n2233 34702754
    [Google Scholar]
  28. Burgess S. Butterworth A. Thompson S.G. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet. Epidemiol. 2013 37 7 658 665 10.1002/gepi.21758 24114802
    [Google Scholar]
  29. Verbanck M. Chen C.Y. Neale B. Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet. 2018 50 5 693 698 10.1038/s41588‑018‑0099‑7 29686387
    [Google Scholar]
  30. Lin H. Wang X. Liu M. Huang M. Shen Z. Feng J. Yang H. Li Z. Gao J. Ye X. Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology. Phytother. Res. 2021 35 5 2651 2664 10.1002/ptr.7012 33452734
    [Google Scholar]
  31. Odaira-Satoh T. Nakagawasai O. Takahashi K. Ono R. Wako M. Nemoto W. Tan-No K. Captopril prevents depressive-like behavior in an animal model of depression by enhancing hippocampal neurogenesis via activation of the ACE2/Ang (1–7)/Mas receptor/AMPK/BDNF pathway. Prog. Neuropsychopharmacol. Biol. Psychiatry 2025 136 111198 10.1016/j.pnpbp.2024.111198 39561916
    [Google Scholar]
  32. Li Y.M. Chen W.D. Zhou B.J. The effect of maleate enalapril and folic acid tablets on cognitive function and depression quantification indicators in patients with H- Type hypertension. Zhejiang J. Integr. Med. 2015 25 6 560 562
    [Google Scholar]
  33. Cao Y. Comparative study of rapid antidepressant effects of angiotensin converting enzyme inhibitors. Thesis 2020
    [Google Scholar]
  34. Nayak V. Patil P.A. Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice. Indian J. Exp. Biol. 2008 46 3 180 184 18432057
    [Google Scholar]
  35. Diniz C.R.A.F. Casarotto P.C. Fred S.M. Biojone C. Castrén E. Joca S.R.L. Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN. Neuropharmacology 2018 135 163 171 10.1016/j.neuropharm.2018.03.011 29550391
    [Google Scholar]
  36. Ping G. Qian W. Song G. Zhaochun S. Valsartan reverses depressive/anxiety-like behavior and induces hippocampal neurogenesis and expression of BDNF protein in unpredictable chronic mild stress mice. Pharmacol. Biochem. Behav. 2014 124 5 12 10.1016/j.pbb.2014.05.006 24844704
    [Google Scholar]
  37. Ayyub M. Najmi A. Akhtar M. Protective effect of irbesartan an angiotensin (AT1) receptor antagonist in unpredictable chronic mild stress induced depression in mice. Drug Res. 2016 67 1 59 64 10.1055/s‑0042‑118172 27756096
    [Google Scholar]
  38. Li Y. Cheng K.C. Liu K.F. Peng W.H. Cheng J.T. Niu H.S. Telmisartan activates PPARδ to improve symptoms of unpredictable chronic mild stress-induced depression in mice. Sci. Rep. 2017 7 1 14021 10.1038/s41598‑017‑14265‑4 29070884
    [Google Scholar]
  39. Wu T.C. Chen H.T. Chang H.Y. Yang C.Y. Hsiao M.C. Cheng M.L. Chen J.C. Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 2013 38 6 871 883 10.1016/j.psyneuen.2012.09.011 23044404
    [Google Scholar]
  40. Hlavacova N. Bakos J. Jezova D. Eplerenone, a selective mineralocorticoid receptor blocker, exerts anxiolytic effects accompanied by changes in stress hormone release. J. Psychopharmacol. 2010 24 5 779 786 10.1177/0269881109106955 19825909
    [Google Scholar]
  41. Abdelhameed A. Abouslima A. Ghanem A.S.H. Ahmed S. Islam R. Sultana S. Khoudir M.A. Propranolol as a novel therapeutic approach for post-stroke anxiety: A clinical review and future directions. Cureus 2024 16 12 e76381 10.7759/cureus.76381 39867038
    [Google Scholar]
  42. Shahzad N. Ahmad J. Khan W. Al-Ghamdi S.S. Ain M.R. Ibrahim I.A.A. Akhtar M. Khanam R. Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress. Pharmacol. Biochem. Behav. 2014 117 79 84 10.1016/j.pbb.2013.12.015 24361783
    [Google Scholar]
  43. Yang L. Zheng L. Wan Y. Chen Z. Li P. Wang Y. Metoprolol, N-acetylcysteine, and escitalopram prevents chronic unpredictable mild stress-induced depression by inhibition of endoplasmic reticulum stress. Front. Psychiatry 2018 9 696 10.3389/fpsyt.2018.00696 30631289
    [Google Scholar]
  44. Feng Y.S. Wang S.P. The effects of different doses of bisoprolol on heart rate variability in patients with PCI and depression. Practical J. Clin. Med. 2020 17 3 148 150
    [Google Scholar]
  45. Wu W. Zeng C. Wu C. Wu T. Pang J. Zhou P. Cao Y. Antidepressant effect of carvedilol on streptozotocin-induced diabetic peripheral neuropathy mice by altering gut microbiota. Biochem. Biophys. Res. Commun. 2024 730 150374 10.1016/j.bbrc.2024.150374 38986219
    [Google Scholar]
  46. Kim H.B. Kim J.S. Jung J.G. The association between aspirin use and depression: A systematic review and meta- analysis of observational studies. Pharmacoepidemiol. Drug Saf. 2020 29 6 613 622 10.1002/pds.5011 32311192
    [Google Scholar]
  47. Berk M. Woods R.L. Nelson M.R. Shah R.C. Reid C.M. Storey E. Fitzgerald S. Lockery J.E. Wolfe R. Mohebbi M. Dodd S. Murray A.M. Stocks N. Fitzgerald P.B. Mazza C. Agustini B. McNeil J.J. Effect of aspirin vs placebo on the prevention of depression in older people. JAMA Psychiatry 2020 77 10 1012 1020 10.1001/jamapsychiatry.2020.1214 32492080
    [Google Scholar]
  48. Li Z.S. Fu Y. Zheng G.Y. Ning L.Y. The effect of clopidogrel on the treatment of coronary heart disease and its impact on patients' psychological state. Cardiovasc. Dis. Electron. J. Integr. Tradit. Chin. West. Med. 2022 10 32 72 74
    [Google Scholar]
  49. Yang T.B. Wang Z.Z. Diao H.B. Pan Z.Q. Gao J. Effect of clopidogrel on inflammatory cytokines and microglial in mice with comorbidity of pain and depression. J. Clin. Anesthesiol. 2024 40 6 629 633
    [Google Scholar]
  50. Leng J.L. Liu J.B. Zhang X.J. Zou X.D. Yu M. Influence of standardized warfarin anticoagulation on psychology and quality of life in patients with cardiogenic cerebral embolism. J. Clin. Neurol. 2018 31 6 401 404 10.3969/j.issn.1004‑1648.2018.06.001
    [Google Scholar]
  51. Farrahizadeh M. Mahmoudian S. Akbarnejad Z. Joghataei M.T. Farhadi M. Shahbazi A. Molecular and behavioral effects of acamprosate in male rats with sodium salicylate-induced tinnitus. Behav. Brain Res. 2025 480 115370 10.1016/j.bbr.2024.115370 39631507
    [Google Scholar]
  52. Gao K. Jiang M. Wu Z. Guo P. Influence of perceived importance of the internet on life satisfaction and health of the older people: An analysis based on intermediary and moderating effects. Front. Public Health 2022 10 952619 10.3389/fpubh.2022.952619 36062097
    [Google Scholar]
  53. Zhao Q. Han Y. Hu X.Y. Zhang S. Zhang L. Wang J. Zhang Q.Q. Tao M.S. Fang J. Yang J. Liu R.G. Sun X. Zhou J. Li X. Mannan-Abdul Zhang H. Liu H. Cao J.L. Transcranial electrical stimulation for relief of peripartum mental health disorders in women undergoing cesarean section with combined spinal–epidural anesthesia: A pilot randomized clinical trial. Front. Psychiatry 2022 13 837774 10.3389/fpsyt.2022.837774 35444569
    [Google Scholar]
  54. Karayol R. Medrihan L. Warner-Schmidt J.L. Fait B.W. Rao M.N. Holzner E.B. Greengard P. Heintz N. Schmidt E.F. Serotonin receptor 4 in the hippocampus modulates mood and anxiety. Mol. Psychiatry 2021 26 6 2334 2349 10.1038/s41380‑020‑00994‑y 33441982
    [Google Scholar]
  55. Chrissobolis S. Luu A.N. Waldschmidt R.A. Yoakum M.E. D’Souza M.S. Targeting the renin angiotensin system for the treatment of anxiety and depression. Pharmacol. Biochem. Behav. 2020 199 173063 10.1016/j.pbb.2020.173063 33115635
    [Google Scholar]
  56. Gong S. Deng F. Renin-angiotensin system: The underlying mechanisms and promising therapeutical target for depression and anxiety. Front. Immunol. 2023 13 1053136 10.3389/fimmu.2022.1053136 36761172
    [Google Scholar]
  57. Lemini C. García-Albor E. Cruz-López B. Matamoros-Trejo G. Márquez-Baltazar S. Herrera-Pérez J.J. Martínez-Mota L. Prolame produces anxiolytic- and antidepressant-like effects in middle-aged female rats with less uterotrophic effects than 17β-estradiol. Eur. J. Pharmacol. 2024 969 176454 10.1016/j.ejphar.2024.176454 38417607
    [Google Scholar]
  58. Carnovale C. Perrotta C. Baldelli S. Cattaneo D. Montrasio C. Barbieri S.S. Pompilio G. Vantaggiato C. Clementi E. Pozzi M. Antihypertensive drugs and brain function: Mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects. Cardiovasc. Res. 2023 119 3 647 667 10.1093/cvr/cvac110 35895876
    [Google Scholar]
  59. Riemer T.G. Villagomez Fuentes L.E. Algharably E.A.E. Schäfer M.S. Mangelsen E. Fürtig M.A. Bittner N. Bär A. Zaidi Touis L. Wachtell K. Majic T. Dinges M.J. Kreutz R. Do β-blockers cause depression? Hypertension 2021 77 5 1539 1548 10.1161/HYPERTENSIONAHA.120.16590 33719510
    [Google Scholar]
  60. Ramondetta L.M. Hu W. Thaker P.H. Urbauer D.L. Chisholm G.B. Westin S.N. Sun Y. Ramirez P.T. Fleming N. Sahai S.K. Nick A.M. Arevalo J.M.G. Dizon T. Coleman R.L. Cole S.W. Sood A.K. Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression. Gynecol. Oncol. 2019 154 3 524 530 10.1016/j.ygyno.2019.07.004 31353053
    [Google Scholar]
  61. Wang T.S. Jing L.J. Therapeutic effect and psychological impact of aspirin plus edaravone on patients with cerebral infarction. World J. Psychiatry 2024 14 5 644 652 10.5498/wjp.v14.i5.644 38808092
    [Google Scholar]
  62. Zhang L. Bao Y. Tao S. Zhao Y. Liu M. The association between cardiovascular drugs and depression/anxiety in patients with cardiovascular disease: A meta-analysis. Pharmacol. Res. 2022 175 106024 10.1016/j.phrs.2021.106024 34890773
    [Google Scholar]
  63. Pajouhesh H. Lenz G.R. Medicinal chemical properties of successful central nervous system drugs. NeuroRx 2005 2 4 541 553 10.1602/neurorx.2.4.541 16489364
    [Google Scholar]
  64. Kucuk M. Kaya M. Kalayci R. Cimen V. Kudat H. Arican N. Elmas I. Korkut F. Effects of losartan on the blood–brain barrier permeability in long-term nitric oxide blockade-induced hypertensive rats. Life Sci. 2002 71 8 937 946 10.1016/S0024‑3205(02)01772‑1 12084390
    [Google Scholar]
  65. Lourenço A.C.M. Santin L.G. Fajemiroye J.O. Oliveira S.S. Napolitano H.B. Studies on charge transfer of enalapril maleate: From solid-state to molecular dynamics. J. Mol. Model. 2023 29 6 197 10.1007/s00894‑023‑05597‑2 37268806
    [Google Scholar]
  66. Shah R. Babar A. Patel A. Dortonne R. Jordan J. Metoprolol-associated central nervous system complications. Cureus 2020 12 5 e8236 10.7759/cureus.8236 32582495
    [Google Scholar]
  67. Chen X. Slättengren T. de Lange E.C.M. Smith D.E. Hammarlund-Udenaes M. Revisiting atenolol as a low passive permeability marker. Fluids Barriers CNS 2017 14 1 30 10.1186/s12987‑017‑0078‑x 29089037
    [Google Scholar]
  68. Beck H. Härter M. Haß B. Schmeck C. Baerfacker L. Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory. Drug Discov. Today 2022 27 6 1560 1574 10.1016/j.drudis.2022.02.015 35202802
    [Google Scholar]
  69. Petitpas I. Bhattacharya A.A. Twine S. East M. Curry S. Crystal structure analysis of warfarin binding to human serum albumin: Anatomy of drug site I. J. Biol. Chem. 2001 276 25 22804 22809 10.1074/jbc.M100575200 11285262
    [Google Scholar]
  70. McDermott J.H. Leach M. Sen D. Smith C.J. Newman W.G. Bath P.M. The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack. Expert Rev. Clin. Pharmacol. 2022 15 7 811 825 10.1080/17512433.2022.2108401 35912831
    [Google Scholar]
  71. Chen L. Ma S. Shi M. Wang Q. Miao Y. A new nitronyl nitroxide radical with salicylic acid framework attenuates blood–brain barrier disruption and oxidative stress in a rat model of middle cerebral artery occlusion. Neuroreport 2022 33 3 129 136 10.1097/WNR.0000000000001764 35139058
    [Google Scholar]
  72. Cavariani M.M. de Mello Santos T. Pereira D.N. de Almeida Chuffa L.G. Felipe Pinheiro P.F. Scarano W.R. Domeniconi R.F. Maternal protein restriction differentially alters the expression of AQP1, AQP9 and VEGFr-2 in the epididymis of rat offspring. Int. J. Mol. Sci. 2019 20 3 469 10.3390/ijms20030469 30678254
    [Google Scholar]
  73. Murck H. Schlageter L. Schneider A. Adolf C. Heinrich D. Quinkler M. Beuschlein F. Reincke M. Künzel H. The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression – Lessons from primary aldosteronism. J. Psychiatr. Res. 2020 130 82 88 10.1016/j.jpsychires.2020.07.006 32798773
    [Google Scholar]
  74. Ali N.H. Al-Kuraishy H.M. Al-Gareeb A.I. Albuhadily A.K. Hamad R.S. Alexiou A. Papadakis M. Saad H.M. Batiha G.E.S. Role of brain renin–angiotensin system in depression: A new perspective. CNS Neurosci. Ther. 2024 30 4 e14525 10.1111/cns.14525 37953501
    [Google Scholar]
  75. Mahmud A. Avramescu R.G. Niu Z. Flores C. Awakening the dormant: Role of axonal guidance cues in stress-induced reorganization of the adult prefrontal cortex leading to depression-like behavior. Front. Neural Circuits 2023 17 1113023 10.3389/fncir.2023.1113023 37035502
    [Google Scholar]
  76. Ran-ran Z. Zhi-gang W. Research progress of neuroactive steroid in the treatment of depression. Acta Neuropharmacologica 2024 14 1 49 56
    [Google Scholar]
  77. Lei L. Heng-Lin W. Ying G. Xiang-Yun J. Relationship between neurosteroids and neuropsychiatric disorders such as anxiety and depression: Research advances. J. Int. Pharm. Res. 2017 44 3 236 239 10.13220/j.cnki.jipr.2017.03.004
    [Google Scholar]
  78. Dityatev A. Seidenbecher C. Morawski M. Brain extracellular matrix: An upcoming target in neurological and psychiatric disorders. Eur. J. Neurosci. 2021 53 12 3807 3810 10.1111/ejn.15336 34077569
    [Google Scholar]
  79. Li Z.Z. Han W.J. Sun Z.C. Chen Y. Sun J.Y. Cai G.H. Liu W.N. Wang T.Z. Xie Y.D. Mao H.H. Wang F. Ma S.B. Wang F.D. Xie R.G. Wu S.X. Luo C. Extracellular matrix protein laminin β1 regulates pain sensitivity and anxiodepression-like behaviors in mice. J. Clin. Invest. 2021 131 15 e146323 10.1172/JCI146323 34156983
    [Google Scholar]
  80. Sanderson E. Glymour M.M. Holmes M.V. Kang H. Morrison J. Munafò M.R. Palmer T. Schooling C.M. Wallace C. Zhao Q. Davey Smith G. Mendelian randomization. Nat. Rev. Methods Primers 2022 2 1 6 10.1038/s43586‑021‑00092‑5 37325194
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673359046250502104101
Loading
Relationship between 21 Medications and Negative Emotions: A Mendelian Randomization Analysis in Asian Populations
Bentham Science Publishers ; https://doi.org/10.2174/0109298673359046250502104101
/content/journals/cmc/10.2174/0109298673359046250502104101
/content/journals/cmc/10.2174/0109298673359046250502104101
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: Medications ; antithrombotic agents ; negative emotions ; salicylic acid ; causal relationship ; cardiovascular drugs

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test